Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: ?
Life Threatening? No
Write-up: Cardiac arrest; cardiopulmonary arrest; NOMI(Non-occlusive mesenteric ischaemia); ventricular fibrillation; This is a spontaneous report from a contactable physician received from the Reglatory Agency. Regulatory authority report number is v21126302. A 16-year-old (also reported as 16-year and 6-month-old) male patient received bnt162b2 (COMIRNATY, Lot Number: FF0843; Expiration Date: 31Oct2021), dose 1 via an unspecified route of administration on 10Aug2021 13:00 as single dose for covid-19 immunisation. Medical history was none. The patient had no family history. There were no points to be considered on the vaccine screening questionnaire (primary diseases, allergies, vaccinations and illnesses within the last one month, medications the patient was taking, past adverse effect history, growth status). The patient''s concomitant medications were not reported. Body temperature before vaccination was 36.2 degrees Centigrade. On 10Aug2021 at 13:00 (the day of vaccination), the patient received the first dose of BNT162b2. On 16Aug2021 at 16:40 (6 days, 3 hours and 40 minutes after the vaccination), the patient experienced cardiac arrest. The patient was immediately transported and admitted to the reporting hospital. On 01Sep2021 (22 days after the vaccination), the outcome of the event was fatal. The course of the event was as follows: On 16Aug2021 at 16:40 (6 days, 3 hours and 40 minutes after the vaccination), the patient was immediately transported the reporting hospital because of cardiopulmonary arrest (CPA). Before arrival to the hospital, automatic external defibrillator (AED) was conducted once. After the arrival, asystole, then VF(ventricular fibrillation) were noted. And return of spontaneous circulation (ROSC) was achieved after the one attempt of direct-current defibrillator (DC). The patient was hospitalized after resuscitated from the CPA. An obvious cause of cardiac arrest was unknown on computerised tomogram (CT), the blood test and electrocardiogram. The patient underwent tracheal intubation, and was managed by artificial respiration under hospitalization. Although targeted temperature management (TTM) was performed, there was no recovery of consciousness. On 31Aug2021 (21 days after the vaccination), blood pressure decreased. NOMI(Non-occlusive mesenteric ischaemia) was diagnosed through CT. On 01Sep2021 (22 days after the vaccination), the death was confirmed. The reporting physician classified the event as serious (Hospitalized) and assessed that the causality between the event and BNT162b2 as unassessable. Other possible cause of the event such as any other diseases was not reported. The patient died on 01Sep2021. It was not reported if an autopsy was performed. The outcome of event ventricular fibrillation was recovered on 16Aug2021, the rest of events was fatal.; Reported Cause(s) of Death: Cardiac arrest; cardiopulmonary arrest; Non-occlusive mesenteric ischaemia
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166